Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas, Adenocarcinoma”

2,115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,115 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03816163
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 393
Early research (Phase 1)Study completedNCT02048384
What this trial is testing

Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Large-scale testing (Phase 3)UnknownNCT00268411
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 80
Not applicableStudy completedNCT04305067
What this trial is testing

PRECISE: Pancreatic Cancer and Exercise

Who this might be right for
Pancreas Adenocarcinoma
Queen's University, Belfast 8
Testing effectiveness (Phase 2)UnknownNCT02863471
What this trial is testing

Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma

Who this might be right for
Adenocarcinomas of the Pancreas
University Hospital Tuebingen 16
Early research (Phase 1)Study completedNCT01198821
What this trial is testing

Gem-TABS in Unresectable Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Not applicableStudy completedNCT06461598
What this trial is testing

Signature for Precise Chemosensitivity Prediction in PDAC

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 365
Testing effectiveness (Phase 2)Ended earlyNCT00967291
What this trial is testing

Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 21
Early research (Phase 1)Not Yet RecruitingNCT07360314
What this trial is testing

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 138
Not applicableTemporarily pausedNCT03444948
What this trial is testing

A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Centre hospitalier de l'Université de Montréal (CHUM) 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT05014776
What this trial is testing

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT04570943
What this trial is testing

Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 103
Not applicableUnknownNCT05228808
What this trial is testing

Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Sohag University 50
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Not applicableNot Yet RecruitingNCT06276803
What this trial is testing

The LINFU® U.S. Registry for the in the General Population Without Risk Factors

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Dysplasia
Adenocyte, LLC 500
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Testing effectiveness (Phase 2)UnknownNCT02329717
What this trial is testing

Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Phoenix Biotechnology, Inc 50
Load More Results